CITATUZUMAB BOGATOX
UNII 23J303Z5CA

Substance Identification & Data

This profile provides standardized clinical and technical data for Citatuzumab Bogatox, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 23J303Z5CA.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 945228-49-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

23J303Z5CA

CAS Registry Number

945228-49-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CITATUZUMAB BOGATOX

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C71694

National Cancer Institute reference terminology for clinical and research data.

INN ID

9046

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Citatuzumab Bogatox. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.